Long term treatment of polymyalgia rheumatica with deflazacort.

OBJECTIVES--To evaluate the long term efficacy and tolerability of deflazacort, a corticosteroid reputed to have only minor side effects, in the treatment of polymyalgia rheumatica (PMR). METHODS--In a prospective open study, deflazacort was administered at an average initial dose of 21.8 mg/day for...

Full description

Saved in:
Bibliographic Details
Main Authors: Cimmino, M A, Moggiana, G, Montecucco, C, Caporali, R, Accardo, S
Format: Artigo
Language:Inglês
Published: 1994
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1005333/
https://ncbi.nlm.nih.gov/pubmed/8017988
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items